CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcareMarket closed

SAR 5.57

Official close

0.0%

Price as of June 25, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Financials

CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcareMarket closed

SAR 5.57

Official close

0.0%

Price as of June 25, 2026 · Market close

Prices may be delayed by up to 30 minutes.

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	428.89M	439.67M	470.47M	566.72M	527.45M
Market Cap Growth	-18.1%	-17.4%	-13.3%	+29.4%	+5.1%
Enterprise Value	400.59M	411.37M	442.69M	534.43M	495.03M
Last Close Price	5.57	5.63	6.02	7.21	6.71
Valuation Multiples
PE Ratio	45.49	72.19	—	43.86	44.44
PS Ratio	2.77	2.82	3.15	4.18	4.29
PB Ratio	4.47	4.58	4.90	5.83	5.39
P/TBV Ratio	4.47	4.58	4.90	5.83	5.39
P/FCF Ratio	41.28	42.32	44.73	—	-324.01
P/OCF Ratio	25.97	26.63	23.67	—	52.49
EV/Sales Ratio	2.58	2.63	2.97	3.95	4.03
EV/EBITDA Ratio	19.17	20.51	21.33	23.89	27.39
EV/EBIT Ratio	23.58	25.48	26.09	27.88	32.13
EV/FCF Ratio	38.56	39.59	42.09	—	-304.10
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.06	0.07	0.07
Debt / EBITDA Ratio	0.29	0.34	0.34	0.20	0.34
Debt / FCF Ratio	0.58	0.58	0.57	—	-4.11
Net Debt / Equity Ratio	-0.30	-0.30	-0.30	-0.29	-0.33
Net Debt / EBITDA Ratio	-1.35	-1.41	-1.36	-1.24	-1.79
Net Debt / FCF Ratio	-2.72	-2.72	-2.69	-6.09	19.84
Efficiency & Liquidity
Asset Turnover	—	1.34	1.28	—	—
Inventory Turnover	—	—	38.62	34.30	—
Quick Ratio	—	—	3.62	4.20	4.51
Current Ratio	—	—	4.00	4.64	5.04
Returns & Yields
Return on Equity (ROE)	+12.7%	-5.2%	+14.3%	+3.5%	—
Return on Assets (ROA)	—	+4.8%	+12.5%	—	—
Return on Invested Capital (ROIC)	+4.5%	+3.7%	+8.5%	+3.5%	+6.3%
Return on Capital Employed (ROCE)	—	—	+15.8%	+17.6%	+14.0%
Earnings Yield	+2.2%	+1.4%	+1.5%	+2.3%	+2.3%
FCF Yield	+2.4%	+2.4%	+2.2%	+0.8%	-0.3%
Dividend Yield	+2.9%	—	+2.6%	—	+1.9%
Payout Ratio	+61.5%	—	—	—	+231.5%
Buyback Yield / Dilution	+0.3%	+1.3%	—	—	—
Total Shareholder Return	+3.2%	+1.3%	+2.6%	—	+1.9%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	428.89M	439.67M	470.47M	566.72M	527.45M
Market Cap Growth	-18.1%	-17.4%	-13.3%	+29.4%	+5.1%
Enterprise Value	400.59M	411.37M	442.69M	534.43M	495.03M
Last Close Price	5.57	5.63	6.02	7.21	6.71
Valuation Multiples
PE Ratio	45.49	72.19	—	43.86	44.44
PS Ratio	2.77	2.82	3.15	4.18	4.29
PB Ratio	4.47	4.58	4.90	5.83	5.39
P/TBV Ratio	4.47	4.58	4.90	5.83	5.39
P/FCF Ratio	41.28	42.32	44.73	—	-324.01
P/OCF Ratio	25.97	26.63	23.67	—	52.49
EV/Sales Ratio	2.58	2.63	2.97	3.95	4.03
EV/EBITDA Ratio	19.17	20.51	21.33	23.89	27.39
EV/EBIT Ratio	23.58	25.48	26.09	27.88	32.13
EV/FCF Ratio	38.56	39.59	42.09	—	-304.10
Leverage & Capital
Debt / Equity Ratio	0.06	0.06	0.06	0.07	0.07
Debt / EBITDA Ratio	0.29	0.34	0.34	0.20	0.34
Debt / FCF Ratio	0.58	0.58	0.57	—	-4.11
Net Debt / Equity Ratio	-0.30	-0.30	-0.30	-0.29	-0.33
Net Debt / EBITDA Ratio	-1.35	-1.41	-1.36	-1.24	-1.79
Net Debt / FCF Ratio	-2.72	-2.72	-2.69	-6.09	19.84
Efficiency & Liquidity
Asset Turnover	—	1.34	1.28	—	—
Inventory Turnover	—	—	38.62	34.30	—
Quick Ratio	—	—	3.62	4.20	4.51
Current Ratio	—	—	4.00	4.64	5.04
Returns & Yields
Return on Equity (ROE)	+12.7%	-5.2%	+14.3%	+3.5%	—
Return on Assets (ROA)	—	+4.8%	+12.5%	—	—
Return on Invested Capital (ROIC)	+4.5%	+3.7%	+8.5%	+3.5%	+6.3%
Return on Capital Employed (ROCE)	—	—	+15.8%	+17.6%	+14.0%
Earnings Yield	+2.2%	+1.4%	+1.5%	+2.3%	+2.3%
FCF Yield	+2.4%	+2.4%	+2.2%	+0.8%	-0.3%
Dividend Yield	+2.9%	—	+2.6%	—	+1.9%
Payout Ratio	+61.5%	—	—	—	+231.5%
Buyback Yield / Dilution	+0.3%	+1.3%	—	—	—
Total Shareholder Return	+3.2%	+1.3%	+2.6%	—	+1.9%